Investor DST Capital LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by DST Capital LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-08-16 13D/A HRGN / Harvard Apparatus Regenerative Technology Inc. 3,756,547
2021-09-10 13D/A 09074M103 / Harvard Apparatus Regenerative Technology, Inc. 3,180,722 3,680,722
2021-06-23 13D/A 09074M103 / Harvard Apparatus Regenerative Technology, Inc. 3,030,722 3,180,722
2020-09-16 13D/A 09074M103 / Harvard Apparatus Regenerative Technology, Inc. 3,030,722 3,030,722
2020-09-15 13D/A 09074M103 / Harvard Apparatus Regenerative Technology, Inc. 3,030,722 3,030,722
2020-04-23 13D/A BSTG / Biostage Inc 500,250 3,030,722
2019-12-10 13D/A BSTG / Biostage Inc 3,030,722 3,030,722
2019-09-05 13D/A BSTG / Biostage Inc 3,030,722 3,030,722
2019-05-13 13D/A BSTG / Biostage Inc 2,530,722 3,030,722
2019-02-20 13D/A BSTG / Biostage Inc 2,025,722 2,530,722
2018-07-06 13D/A BSTG / Biostage Inc 2,025,722
2018-01-10 13D BSTG / Biostage Inc 500,250
2018-01-10 13D BSTG / Biostage Inc 500,250